Exosens revenue and financials
In the fiscal year ended December 2025, Exosens reported revenue of €468.19M (+22.10% year over year). Net income was €42.72M, a net margin of 9.1%.
Fiscal year ending in December. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +22.10%
- 2025 vs 2024
- Net income growth
- +39.23%
- 2025 vs 2024
- Net margin
- 9.1%
- 2024: 8.0%
How Exosens is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 25.6% a year on average over the last 5 years
Compound annual growth rate: from €149.86M in 2020 to €468.19M in 2025.
Revenue has grown for 5 fiscal years in a row
Each fiscal year compared with the one before, up to 2025.
Operating margin rose from 15.0% to 22.2%
Operating income over revenue, 2022 → 2025: 7.2 percentage points.
Profits turn into cash: free cash flow equal to 135% of net income
Totals for fiscal years 2023–2025: free cash flow €123.79M, net income €91.8M.
Shares outstanding down 33.2% in 3 years
Average diluted shares, 2022 → 2025: with fewer shares, each one represents a larger stake in the company.
Profitable in 4 of 5 fiscal years
Positive net income, fiscal years 2021–2025.
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total revenue | 468 | 383 | 292 | 201 | 166 | 150 |
| Cost of revenue | 187 | 158 | 127 | 84.5 | 64.6 | 57.0 |
| Gross profit | 281 | 226 | 165 | 116 | 102 | 92.9 |
| Selling, general and administrative | 139 | 111 | 84.5 | 64.6 | 57.7 | 53.2 |
| Operating income | 104 | 80.6 | 52.6 | 30.1 | 29.5 | 30.0 |
| EBIT | 104 | 80.6 | 52.6 | 30.1 | 29.5 | 30.0 |
| EBITDA | 129 | 96.4 | 71.9 | 43.6 | 35.0 | 34.9 |
| Interest expense | 12.1 | 35.5 | 26.9 | 15.2 | 37.6 | 41.9 |
| Pre-tax income | 88.2 | 45.7 | 20.2 | 17.1 | -150 | -13.2 |
| Income tax | 18.0 | 11.6 | 1.8 | 5.9 | -1.3 | 2.6 |
| Net income | 42.7 | 30.7 | 18.4 | 11.2 | -149 | -15.8 |
| Net income to common shareholders | 70.2 | 28.9 | 7.4 | 0.8 | -149 | -15.8 |
| Basic EPS | 1.38 | 0.69 | 0.24 | 0.01 | -1.96 | — |
| Diluted EPS | 1.38 | 0.69 | 0.24 | 0.01 | -1.96 | — |
| Average shares (basic) | 50.7 | 41.7 | 30.4 | 76.0 | 76.0 | — |
| Average shares (diluted) | 50.7 | 41.7 | 30.4 | 76.0 | 76.0 | — |
| Dividend per share | 0.30 | 0.10 | — | — | — | — |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|
| Total revenue | 253 | — | 219 | — | 187 | 167 | 125 |
| Cost of revenue | 95.0 | — | 81.9 | — | 77.1 | 72.2 | 54.6 |
| Gross profit | 158 | — | 138 | — | 110 | 94.6 | 70.4 |
| Selling, general and administrative | 79.3 | — | 69.6 | — | 57.9 | 45.6 | 38.9 |
| Operating income | 32.7 | — | 49.5 | — | 32.8 | 33.4 | 19.2 |
| EBIT | 32.7 | — | 49.5 | — | 32.8 | 33.4 | 19.2 |
| EBITDA | 44.6 | — | 68.7 | — | 47.4 | 41.2 | 30.7 |
| Interest expense | 6.3 | — | 6.6 | — | 27.4 | 17.4 | 9.5 |
| Pre-tax income | 25.2 | — | 40.7 | — | 5.0 | 10.5 | 9.7 |
| Income tax | 9.9 | — | 11.1 | — | 2.1 | 0.4 | 1.4 |
| Net income | 15.3 | — | 27.9 | — | 2.9 | 10.1 | 8.3 |
| Net income to common shareholders | 15.3 | — | 27.9 | — | -2.3 | -0.9 | 8.3 |
| Basic EPS | 0.30 | — | 0.55 | — | -0.07 | — | — |
| Diluted EPS | 0.30 | — | 0.55 | — | -0.07 | — | — |
| Average shares (basic) | 50.4 | — | 50.8 | — | 32.5 | — | — |
| Average shares (diluted) | 50.4 | — | 50.8 | — | 32.5 | — | — |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total assets | 879 | 817 | 656 | 529 | 461 | 598 |
| Current assets | 280 | 314 | 193 | 145 | 113 | 119 |
| Cash and equivalents | 68.6 | 117 | 15.5 | 29.0 | 15.9 | 31.1 |
| Short-term investments | 0.0 | 0.1 | 0.1 | 22.5 | — | — |
| Receivables | 106 | 104 | 98.5 | 32.7 | 44.9 | 33.8 |
| Inventory | 105 | 93.0 | 78.5 | 55.7 | 45.0 | 46.2 |
| Net property, plant and equipment | 128 | 104 | 82.8 | 60.5 | 46.5 | 43.7 |
| Goodwill | 233 | 189 | 174 | 140 | 258 | 400 |
| Other intangible assets | 146 | 140 | 142 | 129 | 38.5 | 32.6 |
| Long-term investments | 4.5 | 4.3 | 4.2 | 3.0 | 1.8 | 1.8 |
| Current liabilities | 114 | 107 | 110 | 72.5 | 53.5 | 59.0 |
| Accounts payable | 31.2 | 26.0 | 32.3 | 22.9 | 15.9 | 10.7 |
| Long-term debt | 249 | 248 | 301 | 238 | 217 | 427 |
| Total debt | 266 | 261 | 318 | 255 | 226 | 452 |
| Total liabilities | 433 | 404 | 452 | 346 | 288 | 501 |
| Total equity (incl. minority) | 446 | 413 | 204 | 183 | 172 | 97.1 |
| Retained earnings | 94.5 | 56.9 | 26.2 | 7.8 | -308 | -109 |
| Minority interest | — | — | — | — | 0.0 | — |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|---|---|
| Total assets | 895 | 879 | 867 | 817 | 784 | 656 |
| Current assets | 306 | 280 | 314 | 314 | 316 | 193 |
| Cash and equivalents | 68.8 | 68.6 | 89.8 | 117 | 123 | 15.5 |
| Short-term investments | 0.4 | 0.0 | — | 0.1 | 36.9 | 0.1 |
| Receivables | 102 | 106 | 111 | 104 | 60.3 | 98.5 |
| Inventory | 123 | 105 | 106 | 93.0 | 94.9 | 78.5 |
| Net property, plant and equipment | 144 | 128 | 119 | 104 | 89.3 | 82.8 |
| Goodwill | 233 | 233 | 209 | 189 | 174 | 174 |
| Other intangible assets | 114 | 146 | 151 | 140 | 199 | 142 |
| Long-term investments | 9.1 | 4.5 | 3.9 | 4.3 | 4.6 | 4.2 |
| Current liabilities | 130 | 114 | 125 | 107 | 112 | 110 |
| Accounts payable | 35.6 | 31.2 | 30.9 | 26.0 | 35.2 | 32.3 |
| Long-term debt | 251 | 249 | 247 | 248 | 249 | 301 |
| Total debt | 269 | 266 | 268 | 261 | 261 | 318 |
| Total liabilities | 444 | 433 | 438 | 404 | 402 | 452 |
| Total equity (incl. minority) | 451 | 446 | 430 | 413 | 382 | 204 |
| Retained earnings | 94.7 | 94.5 | 79.7 | 56.9 | 19.8 | 26.2 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | 100.0 | 94.3 | 50.5 | 47.5 | 42.7 | 44.1 |
| Depreciation and amortization | 29.2 | 19.5 | 21.8 | 15.1 | 6.9 | 6.2 |
| Capital expenditure | -50.1 | -40.0 | -30.9 | -21.8 | -19.6 | -13.8 |
| Investing cash flow | -121 | -71.4 | -99.6 | -55.5 | -21.3 | -13.8 |
| Financing cash flow | -25.2 | 76.9 | 35.5 | 20.3 | -36.8 | -5.0 |
| Dividends paid | -5.1 | 0.0 | — | — | — | — |
| Share repurchases | -8.8 | -0.3 | 0.0 | — | — | — |
| Debt issued | 1.4 | 250 | 65.1 | 40.0 | 231 | 10.0 |
| Debt repaid | -7.1 | -315 | -7.5 | -4.7 | -271 | -5.7 |
| Effect of exchange rates | -0.8 | 0.4 | 0.2 | 0.1 | 0.2 | -0.3 |
| Net change in cash | -47.1 | 100 | -13.5 | 12.4 | -15.2 | 25.1 |
| Free cash flow | 49.9 | 54.3 | 19.5 | 25.7 | 23.1 | — |
| Levered free cash flow | 50.7 | 2.4 | -29.6 | 26.1 | -8.9 | — |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | 63.9 | — | 44.1 | — | 39.8 | 34.6 | 15.9 |
| Depreciation and amortization | 13.9 | — | 19.1 | — | 15.8 | 10.3 | 11.5 |
| Capital expenditure | -32.5 | — | -20.8 | — | -18.3 | -15.8 | -15.1 |
| Investing cash flow | -39.3 | — | -57.0 | — | -19.2 | -76.8 | -22.8 |
| Financing cash flow | -24.8 | — | -13.1 | — | 87.0 | 40.9 | -5.4 |
| Dividends paid | -15.2 | — | -5.1 | — | — | — | — |
| Share repurchases | -1.0 | — | -0.2 | — | — | — | — |
| Debt issued | 2.2 | — | — | — | 250 | 62.2 | 2.9 |
| Debt repaid | -2.2 | — | -2.8 | — | -313 | -7.5 | — |
| Effect of exchange rates | 0.4 | — | -0.7 | — | 0.1 | 0.3 | -0.1 |
| Net change in cash | 0.3 | — | -26.8 | — | 108 | -1.0 | -12.5 |
| Free cash flow | 31.4 | — | 23.3 | — | 21.5 | 18.7 | 0.8 |
| Levered free cash flow | -4.3 | — | 17.1 | — | 32.2 | -29.6 | — |
Financial statements of similar companies
Companies in the group: same industry, similar size
